Oximeters News
-
BioIntelliSense Launches Patented, FDA-cleared Pulse Oximetry (SpO2) Sensor Technology that Addresses Skin Pigmentation and Motion Monitoring Challenges
Breakthrough pulse oximetry (SpO2 ) optical sensor solution offers medical-grade accuracy of oxygen level measurement across skin tones and while in motion Patented SpO2 sensor chipset, integrated processing and reference design capability to power the next generation of medical and consumer wearable devices BioIntelliSense, a continuous health monitoring and clinical intelligence company, ...
-
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies to deliver oxygen to areas of the body where it is needed most, today announced completion and topline data from the open-label, Phase 1b clinical trial of its novel, diffusion-enhancing therapeutic, trans sodium crocetinate ...
By CervoMed
-
How Remote Patient Monitoring Enhances Telehealth
The demand for telehealth in the United States has grown considerably in the past ten years. In 2017, patients were waiting an average of nearly 30 days to see their doctor, whose accessibility is growing increasingly scarce. It’s little wonder that from 2010-2017, the use of telehealth in hospitals increased from 35% to 76%, with nearly every state Medicaid program covering various ...
-
The FCC’s COVID-19 Telehealth Program Secures an Additional $250 Million in Funding
What is the COVID-19 Telehealth Program? The FCC launched the COVID-19 Telehealth program as a part of the overarching CARES Act in March 2020 to help nonprofit and public health care providers implement connected care services in response to the COVID-19 pandemic. $200 million dollars in funding was distributed to eligible providers who had qualified for the program via the FCC’s ...
-
HealthTech Arkansas names five early-stage companies for latest cohort
HealthTech Arkansas announced the five early-stage companies selected for the 2020 HealthTech Arkansas healthcare accelerator. The accelerator is supported by 11 Arkansas healthcare organizations, including Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, ...
By Zeto, Inc.
-
C. Raymond Larkin to be Strategic Advisor at Respiratory Motion, Inc.
Respiratory Motion Inc. (RMI) today announced that C. Raymond Larkin Jr. will act as a Strategic Advisor to the Company. Mr. Larkin was previously President and Chief Executive Officer of Nellcor Puritan Bennett, Inc., one of the world's preeminent respiratory products companies. Under Mr. Larkin's leadership over 15 years, Nellcor grew to nearly $1 billion in revenues through the development ...
-
RemetricHealth’s Integrated Telehealth/Remote Patient Monitoring Solutions Bridge the Gap Between Patients and Providers Amid Ongoing COVID-19 Crisis
RemetricHealth, a leading remote patient monitoring (RPM) and telehealth services company that has been serving the healthcare industry for more than a decade, has announced that its telehealth capabilities, in conjunction with its biometric monitoring devices, are helping connect patients and providers in a time when continuity of care can be challenging due to COVID-19. The telehealth model is ...
-
OXITONE, the World`s First FDA-Cleared Wrist Sensor, Pulse Oximeter Monitoring Device to Detect the Early Symptoms of COVID-19 and Other Chronic Diseases
IRVINE, Calif., May 28, 2020 (Newswire.com) - betweenMD is very excited to announce our partnership with Oxitone, makers of the world's first FDA-cleared risk monitoring device. Oxitone developed a wearable monitoring device, specifically designed and FDA-cleared for in-home use for patients with respiratory failure. This unique solution is for prolonged monitoring for those at risk for ...
-
Research Presented at LINC Suggests the Profusa Lumee® Oxygen Platform May Improve Clinical Management of Patients with Critical Limb Ischemia
Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced research findings that suggest the company’s Lumee® Oxygen Platform may help improve the clinical management of patients with critical limb ischemia (CLI) who are undergoing endovascular revascularization treatment (EVT). The data, from a recent post-market clinical study ...
-
Oxitone Medical has launched mass-production of new generation devices
We are excited to announce that Oxitone Medical, a world leader in wrist-wearable medical technologies, has begun mass-producing and delivering the new generation of the world’s first FDA-cleared wrist-sensor pulse oximetry monitor to our customers. In the last few months, we have been tirelessly working to release a new generation product with extended capabilities. We believe that our ...
-
Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen
Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced it has received Conformité Européenne (CE) Mark approval to market its Wireless Lumee® Oxygen Platform for continuous, real-time monitoring of tissue oxygen in patients with potential acute and/or chronic changes in tissue oxygen levels who may benefit from ...
-
Expanded Medical Calibration Services
The company extends its' medical services support to cover defibrillators, pulse oximetry, tympanic and arterial temperature instruments. All using the latest reference calibration equipment. Defibrillators and AEDs  from all leading manufacturers can be calibrated. Calibration of personal and laboratory pulse oximeters and all vital signs meters can also be undertaken. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you